Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Cerebral Palsy Spectrum Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 638 | 419 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 480 | 254 |
|
Leukodystrophy and Leukoencephalopathy, Adult Onset Panel PreventionGenetics, part of Exact Sciences United States | 46 | 37 |
|
Leukodystrophy and Leukoencephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 202 | 212 |
|
Invitae Hereditary Spastic Paraplegia Comprehensive Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 98 | 62 |
|
GJC2 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 3 | 1 |
|
GJC2 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 3 | 1 |
|
Baylor Genetics United States | 3 | 1 |
|
Hereditary Lymphedema via the GJC2 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Inherited Metabolic Disorders Panel Dhiti Omics Technologies Private Ltd India | 376 | 317 |
|
Leukodystrophy and leukoencephalopathy panel. NGS panel of 74 genes. Genologica Medica Spain | 96 | 74 |
|
Lymphatic malformations and related disorders panel. NGS panel of 11 genes. Genologica Medica Spain | 31 | 11 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Genologica Medica Spain | 100 | 60 |
|
Leukodystrophy, hypomyelinating: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 18 | 18 |
|
Fulgent Genetics United States | 507 | 135 |
|
Hypomyelinating Leukodystrophy NGS Panel Fulgent Genetics United States | 225 | 62 |
|
Fulgent Genetics United States | 535 | 152 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.